Make Money, Make Time

Make Money, Make Time

Share this post

Make Money, Make Time
Make Money, Make Time
5 Charts For The Week

5 Charts For The Week

28/07/2025

Oliver | MMMT Wealth's avatar
Oliver | MMMT Wealth
Jul 28, 2025
∙ Paid
11

Share this post

Make Money, Make Time
Make Money, Make Time
5 Charts For The Week
1
Share

Hi all 👋

Continuing my new series which gets released every Sunday/Monday before market open where I look at some potential adds/trims/buys/sells for the week.

The first 3 will be open to all and the last 2 will be for paid subscribers.

Make Money, Make Time is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.


1. United Health | UNH

Paid subs will know exactly when I’ve added/trimmed and bought UNH.

To be honest, price action still looks quite poor and there’s every chance we see the $240 zone come into action especially with earnings being released tomorrow before the market open. Management added another 45 minutes to their conference call to allow additional time to discuss results. This likely means results weren’t great and the new CEO will be discussing the plan moving forward quite a lot.

Either way, if UNH drops I’ll just add more because I think they’re fundamentally and technically undervalued today which means I’m very happy to hold through some volatility. One or two bad earnings report won’t change that.


2. Albermarle Corporation | ALB

Last week ALB broke this downtrend of lower highs and lower lows which essentially has been going on since 2023 and paid subs will know exactly what I did here.

Make Money, Make Time is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

An ideal entry point would be around the blue line if ALB can retrace back there and turn that original level into a support. That would confirm a potential change in trend. Ultimately, lithium demand should be very high, and although prices have moved cyclically, demand is not. With near term cash flow challenges because of their expansion projects, we should start to see the numbers at ALB align with the huge opportunity ahead for them.


3. AbCellera Biologics | ABCL

ABCL is currently a watchlist position for me, but technically I love it and fundamentally the future is bright.

In an ideal world, I’d love ABCL to come back to this $4 level after its recent breakout and confirm support there before its next leg up. Realistically, there’s no knowing whether or not this will happen anytime soon and if ABCL is a “moonshot” stock like it is for me, the difference between $5 and $4 for a first buy shouldn’t be too much of a material difference. I think I’ll be buying ABCL sometime soon but just watching price action quite closely for the time being. I’ll update paid subs as and when necessary.

Keep reading with a 7-day free trial

Subscribe to Make Money, Make Time to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Oliver Cull
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share